HIV infection, HAART, and endothelial adhesion molecules: current perspectives
- 4 April 2004
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 4 (4), 213-222
- https://doi.org/10.1016/s1473-3099(04)00971-5
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Atherosclerosis and HIV in the highly active antiretroviral therapy eraAIDS, 2003
- Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone TherapyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patientsBlood Coagulation & Fibrinolysis, 2003
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progressionResearch in Immunology, 1997
- Abnormal Levels of Circulating Adhesion Molecules in HIV-1 Infection with Characteristic Alterations in Opportunistic InfectionsClinical Immunology and Immunopathology, 1996
- Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infectionInfection, 1995
- Increased Concentrations of Soluble Tumor Necrosis Factor Receptor 75 but Not of Soluble Intercellular Adhesion Molecule-1 Are Associated with the Decline of CD4+ Lymphocytes in HIV InfectionClinical Immunology and Immunopathology, 1994
- Increased Levels of Serum Intercellular Adhesion Molecule 1 in HIV Infection Are Related to Immune ActivationInternational Archives of Allergy and Immunology, 1993
- Infection of the Retina by Human Immunodeficiency Virus Type INew England Journal of Medicine, 1987